1. Read RC. Neisseria meningitidis and meningococcal disease: recent discoveries and innovations. Curr Opin Infect Dis 2019;32:601-8.
2. Booy R, Gentile A, Nissen M, Whelan J, Abitbol V. Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies. Hum Vaccin Immunother 2019;15:470-80.
https://doi.org/10.1080/21645515.2018.1532248
3. Gasparini R, Amicizia D, Lai PL, Panatto D. Neisseria meningitidis, pathogenetic mechanisms to overcome the human immune defences. J Prev Med Hyg 2012;53:50-5.
4. Gasparini R, Amicizia D, Lai PL, Panatto D. Meningococcal B vaccination strategies and their practical application in Italy. J Prev Med Hyg 2015;56:E133-9.
5. McNeil LK, Zagursky RJ, Lin SL, Murphy E, Zlotnick GW, Hoiseth SK, et al. Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease. Microbiol Mol Biol Rev 2013;77:234-52.
https://doi.org/10.1128/MMBR.00056-12
6. Goulet DR, Atkins WM. Considerations for the Design of Antibody-Based Therapeutics. J Pharm Sci 2020;109:74-103.
https://doi.org/10.1016/j.xphs.2019.05.031
7. Chiu ML, Gilliland GL. Engineering antibody therapeutics. Curr Opin Struct Biol 2016;38:163-73.
https://doi.org/10.1016/j.sbi.2016.07.012
8. Bemani P, Mohammadi M, Hakakian A. ScFv Improvement Approaches. Protein Pept Lett 2018;25:222-9.
https://doi.org/10.2174/0929866525666171129225436
9. Yarian F, Kazemi B, Bandehpour M. Identification and characterization of a novel single-chain variable fragment (scFv) antibody against Neisseria meningitidis factor H-binding protein (fHbp). J Med Microbiol 2018;67:820-7.
https://doi.org/10.1099/jmm.0.000744
10. Bandehpour M, Yarian F, Ahangarzadeh S. Bioinformatics evaluation of novel ribosome display-selected single chain variable fragment (scFv) structure with factor H binding protein through docking. Journal of Theoretical and Computational Chemistry 2019;16:1750021.
https://doi.org/10.1142/S0219633617500213
11. Rafighdoust H, Ahangarzadeh S, Yarian F, Taheri RA, Lari A, Bandehpour M, et al. Bioinformatics prediction and experimental validation of VH antibody fragment interacting with Neisseria meningitidis factor H binding protein. Iran J Basic Med Sci 2020;23:1053-8.
12. Bandehpour M, Yarian F, Lari A, Farnia P. In silico evaluation of the interactions among two selected single chain variable fragments (scFvs) and ESAT-6 antigen of Mycobacterium tuberculosis. Journal of Theoretical and Computational Chemistry.2017;16:1750069.
https://doi.org/10.1142/S0219633617500699
13. Dunbar J, Krawczyk K, Leem J, Marks C, Nowak J, Regep C, et al. SAbPred: a structure-based antibody prediction server. Nucleic Acids Res 2016;44:W474-78.
https://doi.org/10.1093/nar/gkw361
14. Vajda S, Yueh C, Beglov D, Bohnuud T, Mottarella SE, Xia B, et al. New additions to the ClusPro server motivated by CAPRI. Proteins 2017;85:435-44.
https://doi.org/10.1002/prot.25219
15. Desta IT, Porter KA, Xia B, Kozakov D, Vajda S. Performance and Its Limits in Rigid Body Protein-Protein Docking. Structure 2020;28:1071-81.e3.
https://doi.org/10.1016/j.str.2020.06.006
16. Laskowski RA, Jabłońska J, Pravda L, Vařeková RS, Thornton JM. PDBsum: Structural summaries of PDB entries. Protein Sci 2018;27:129-34.
https://doi.org/10.1002/pro.3289
17. Yarian F, Bandehpour M, Seyed N, Kazemi B. Cloning, expression and purification of the factor H binding protein and its interaction with factor H. Iran J Microbiol 2016;8:29-35.
18. Byrne B, Stack E, Gilmartin N, O'Kennedy R. Antibody-based sensors: principles, problems and potential for detection of pathogens and associated toxins. Sensors 2009;9:4407-45.
https://doi.org/10.3390/s90604407
19. Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol 2012;799:1-20.
https://doi.org/10.1007/978-1-61779-346-2_1
20. Payandeh Z, Rajabibazl M, Mortazavi Y, Rahimpour A, Taromchi AH, Dastmalchi S. Affinity maturation and characterization of the ofatumumab monoclonal antibody. J Cell Biochem 2019;120:940-50.
https://doi.org/10.1002/jcb.27457 [
DOI:10.1097/QCO.0000000000000606]